Maldigestion and malabsorption of C-13 labelled tripalmitin in gastrostomy-fed patients with cystic fibrosis




Laiho KM, Gavin J, Murphy JL, Connett GJ, Wootton SA

PublisherCHURCHILL LIVINGSTONE

2004

 Clinical Nutrition

CLINICAL NUTRITION

CLIN NUTR

23

3

347

353

7

0261-5614

DOIhttps://doi.org/10.1016/j.clnu.2003.08.002



Conclusions: These results highlight differences between gastrostomy fed patients with cystic fibrosis to both digest and absorb dietary lipid. There is a need to extend these observations and apply this approach to patients both with and without pancreatic enzyme replacement therapy. (C) 2003 Elsevier Ltd. All rights reserved.




Last updated on 14/10/2025 09:45:50 AM